Actively Recruiting
Phase 2 Study of Adebrelimab Immunotherapy with Probiotics and Higher-Dose Radiotherapy Combined with Chemotherapy for Limited-Stage Small Cell Lung Cancer
Led by Fudan University · Updated on 2026-02-11
60
Participants Needed
1
Research Sites
34 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the treatment of limited-stage small cell lung cancer LS-SCLC by exploring whether increasing the dose of radiotherapy along with immunotherapy improves outcomes. This phase II study aims to evaluate the safety and effectiveness of combining simultaneous integrated boost hyperfractionation radiotherapy with probiotics and Adebrelimab monoclonal antibody consolidation therapy. The trial seeks to understand if this combined approach can offer better disease control after standard chemotherapy and radiotherapy. Participants are divided into two groups. One group receives chest radiotherapy starting before their fourth cycle of etoposide and cisplatin chemotherapy, combined with probiotics given before radiotherapy, followed by Adebrelimab 1200 mg starting the week after radiotherapy and continuing every three weeks for two years. The other group receives the same radiotherapy and Adebrelimab schedule but without probiotics. Radiotherapy doses are given twice daily for 30 sessions, targeting different areas of the chest. Throughout the study, participants will be monitored for progression-free survival over one year and their response one month after completing radiotherapy. Researchers will also assess overall survival, survival without distant metastasis, and any adverse reactions up to one year. Follow-up includes regular assessments to track treatment effects and safety, with the total participation lasting at least one year after treatment begins.
CONDITIONS
Brief Title
Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)
Research Team
X
Xingwen Fan
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here